Monday, November 28, 2011

FDA Breast Cancer Drug Useless, But OK To Prescribe

'Several years after declaring it to be not only medically useless but also dangerous, the US Food and Drug Administration (FDA) has officially withdrawn approval for the $100,000 breast cancer drug Avastin. In a statement, FDA Commissioner Margaret Hamburg said that Avastin has never been proven to be safe or effective, but also in the same breath noted that doctors can still prescribe the drug if they feel like it.

"FDA recognizes how hard it is for patients and their families to cope with metastatic breast cancer and how great a need there is for more effective treatments," Hamburg is quoted as saying by The Pittsburgh Tribune-Review. "But patients must have confidence that the drugs they take are both safe and effective for their intended use."

After being rapidly approved for use by the FDA back in 2007, Avastin quickly generated more than $1.7 billion for its producer Genentech within the first year. When the FDA finally got around to actually reviewing the drug after approving it, though, the agency discovered that Avastin does not lengthen the lives of breast cancer patients, and that it carries with it severe side effects that include death.'

No comments:

Post a Comment